All lobbying filings

The KPM Group DC LLC

The KPM Group DC LLC filed a Q3 amendment for Sebela Pharmaceuticals on October 7, 2025, reporting $40,000 in lobbying income.

Lobbying for Sebela Pharmaceuticals · Developing therapies for gastrointestinal diseases and women's health

As filed: THE KPM GROUP DC LLC for SEBELA PHARMACEUTICALS.

All filings by The KPM Group DC LLC · Everything Sebela Pharmaceuticals has reported

Filing · LD-2 quarterly report Q3 amendment

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 7, 2025

Income

$40,000

What the client paid this registrant for the period.

Client based in

Georgia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Requesting CMS change guidance on Bowel Prep Coverage for Screening Colonoscopies Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.